Root Financial Partners’s Anika Therapeutics ANIK Stock Holding History

Root Financial Partners’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-67	Closed	-$972	–	553
2026 Q1	$972	Buy	+67	New	+$778	﹤0.01%	2626

Other funds holding ANIK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Root Financial Partners's ANIK Position: Q2 2026 in Review

Root Financial Partners sold out of Anika Therapeutics (ANIK) in Q2 2026, closing a stake of 67 shares — an estimated $972 sold.

Root Financial Partners first reported a position in ANIK in Q1 2026 and held it in 1 quarter. The position peaked at $972 in Q1 2026. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

Root Financial Partners reported no remaining Anika Therapeutics position as of Q2 2026 after selling out during the quarter.
Root Financial Partners sold 67 Anika Therapeutics shares in Q2 2026, an estimated $972.
Root Financial Partners first reported a position in Anika Therapeutics in Q1 2026 and held it in 1 quarter.
Root Financial Partners's Anika Therapeutics position peaked at $972 in Q1 2026.
133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.